Voom Medical Devices, Inc.
$76.9K 190 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Daiichi Sankyo Europe GmbH
Daiichi Sankyo Europe GmbH reported $77,266.66 across General Payments, Research, and Ownership to 33 physicians and teaching hospitals across 33 transactions.
- $77.3K Below-median payer
- All-tracks total
- 33 Below-median volume
- Transactions
- 33 Below-median reach
- Recipients
- +$43.9K
- General Payments vs PY2023
Daiichi Sankyo Europe GmbH reported $77,266.66 across all CMS Open Payments tracks (General + Research + Ownership) to 33 physicians and teaching hospitals in Program Year 2024 - ranking #1248 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $77,266.66, averaging $2.3K per recipient.
Daiichi Sankyo Europe GmbH's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
20/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer daiichi-sankyo-europe-gmbh Daiichi Sankyo Europe GmbH
$77.3K · #1248/1,925 · 0.0% industry · PY2024
- TOT $77.3K
- RANK #1248
- SHARE 0.0%
- TXN 33
- RCP 33
- CAT 4
- GEN $77.3K
- ΔGEN +$43.9K
- TOP1 42.1%
- PY 2024
Volume peers
Nearest volume peer: Voom Medical Devices, Inc. ($76.9K)
Daiichi Sankyo Europe GmbH sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Daiichi Sankyo Europe GmbH's CMS-reported General Payments increased by $43.9K (+131.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DAIICHI SANKYO EUROPE GMBHPY2023: DAIICHI SANKYO EUROPE GMBHPY2024: Daiichi Sankyo Europe GmbH. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $33,368.85
- PY2024
- $77,266.66
What the Data Shows for Daiichi Sankyo Europe GmbH
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Daiichi Sankyo Europe GmbH that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $45.2K, accounting for 58.4% of this company's General Payments and 12 transactions.
General Payment Breakdown by Type
Daiichi Sankyo Europe GmbH made 4 types of general payments. "Consulting Fee" is the largest category at $45.2K, 58.4% of General Payments.
Daiichi Sankyo Europe GmbH reports 4 general-payment categories - the top three are Consulting Fee (58.4%), Travel and Lodging (39.9%), and Education (0.8%). The remaining 1 category make up 0.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Daiichi Sankyo Europe GmbH divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $45.2K | 12 | 58.4% |
| Travel and Lodging | $30.8K | 15 | 39.9% |
| Education | $652.73 | 1 | 0.8% |
| Food and Beverage | $611.42 | 5 | 0.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $72,089.26 (93.3%) of $77,266.66 in this company's General Payments records across 8 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Daiichi Sankyo Europe GmbH
The five named recipients with the highest reported General Payments from this company
- 1
Robert P Giugliano
$32,517.52 across 13 reported transactions
- 2
Sung Hee Leslie Cho
$20,204.74 across 10 reported transactions
- 3
Shanu Modi
$12,360.30 across 4 reported transactions
- 4
Edward Jeffrey Bloch
$3,750.00 across 1 reported transactions
- 5
Harry Erba
$3,256.70 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Daiichi Sankyo Europe GmbH ranks #1248 of 1,925 by total payments (bottom 35% by spend) but is notably more concentrated than that alone would suggest -- #602 of 1,838 by HHI (top 33% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- SRS Medical Systems, Inc. : $54.6K total payments, HHI 2811
- Wardlow Enterprises : $3.5K total payments, HHI 2803
- Stability Biologics, LLC : $235.6K total payments, HHI 2790
- Elekta Instrument AB : $354.2K total payments, HHI 2789
- Masimo Corporation : $2.6M total payments, HHI 2786
- Phadia AB : $11.9K total payments, HHI 2782
- Daiichi Sankyo Europe GmbH (this company) : $77.3K total payments, HHI 2769
- Pramand LLC : $22.8K total payments, HHI 2763
- Cleerly, Inc. : $157.5K total payments, HHI 2760
- Biodynamik, Inc : $23.6K total payments, HHI 2759
- Blue Sky Bio, LLC : $314.2K total payments, HHI 2746
- BTG International, Inc. : $670.8K total payments, HHI 2745
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Daiichi Sankyo Europe GmbH's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Daiichi Sankyo Europe GmbH.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Daiichi Sankyo Europe GmbH.
Showing 6 of 1,924 companies with CMS-reported payment data.
TearLab Corp
$77.8K 325 recipients
Compare payment profiles
Guard Medical Inc.
$77.8K 295 recipients
Compare payment profiles
Biocon Biologics Inc
$76.3K 733 recipients
Compare payment profiles
Team 1, Llc
$78.3K 409 recipients
Compare payment profiles
Kuros Biosciences AG
$76.3K 6 recipients
Compare payment profiles
Put this to use
Daiichi Sankyo Europe GmbH ranks #1248 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Daiichi Sankyo Europe GmbH. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.